首页|安徽省部分地区1-12岁健康儿童水痘减毒活疫苗接种不良反应观察

安徽省部分地区1-12岁健康儿童水痘减毒活疫苗接种不良反应观察

Adverse reactions following vaccination with varicella attenuated live vaccine among healthy children aged 1-12 years:an observational study in areas of Anhui province

扫码查看
目的 评价适龄儿童一款水痘减毒活疫苗(Varicella attenuated live vaccine,VarV)接种不良反应发生率.方法 在安徽省5个地市预防接种门诊招募1-12岁健康儿童,观察接种1剂次VarV后0-30 d不良反应,分析不良反应发生率.结果 本研究共纳入9 169例受试者,接种VarV后不良反应总发生率为1.09%(100例),其中局部反应、全身反应发生率分别为0.69%(63例)、0.46%(42例),各以接种部位疼痛(0.40%)和发热(0.26%)发生率最高,未发生3级/4级或严重不良反应和特殊关注不良事件.1-3岁、4-12岁受试者不良反应发生率分别为1.47%(64/4 347)、0.75%(36/4 822)(x2=11.16,P<0.001).结论 1-12岁健康儿童接种1剂次VarV后不良反应轻微,发生率在预期范围内.
Objective To evaluate incidences of adverse reactions following vaccination with varicella attenuated live vaccine(VarV)among age-eligible children.Methods We recruited healthy children aged 1-12 years from vaccination clinics in five prefectures of Anhui province and followed them for adverse reactions 0-30 days after one-dose of VarV to determine incidences.Results A total of 9 169 subjects were included in the study.The overall incidence of adverse reactions after VarV vaccination was 1.09%(100 cases),with 0.69%(63 cases)local reactions and 0.46%(42 cases)systemic reactions;respective highest incidences were 0.40%for injection-site pain and 0.26%for fever.No level 3/level 4,serious adverse reactions or adverse events of special concern were reported.Incidences of adverse reactions were 1.47%(64/4 347)for 1-3-year-olds and 0.75%(36/4 822)for 4-12 year-olds(x2=11.16,P<0.001).Conclusion Adverse reactions were mild after a single dose of VarV vaccination among 1-12-year-old healthy children,and incidences of adverse reactions were less than expected.

Varicella attenuated live vaccineVaccinationAdverse reaction

王斌冰、李涛、孟凡亚、唐继海、罗献伟、徐海洋、程育慧、秦伟、吴晗晗、葛轲、徐庆华

展开 >

安徽省疾病预防控制中心,安徽合肥 230601

阜阳市疾病预防控制中心,安徽阜阳 236000

宣城市疾病预防控制中心,安徽宣城 242000

六安市疾病预防控制中心,安徽六安 237000

亳州市疾病预防控制中心,安徽亳州 236800

芜湖市疾病预防控制中心,安徽芜湖 241000

展开 >

水痘减毒活疫苗 预防接种 不良反应

公共卫生安全教育部重点实验室开放基金安徽省卫生健康科研项目

QW2019-5AHWJ2023A20369

2024

中国疫苗和免疫
中国疾病预防控制中心

中国疫苗和免疫

CSTPCD北大核心
影响因子:2.311
ISSN:1006-916X
年,卷(期):2024.30(4)